New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.

Pilar Arrazola, María Fernández Prada, Ángel Gil, José Gómez Rial, Cristina Hernán, Rosario Menéndez, Antoni Trilla, Raúl Ortiz de Lejarazu
{"title":"New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.","authors":"Pilar Arrazola, María Fernández Prada, Ángel Gil, José Gómez Rial, Cristina Hernán, Rosario Menéndez, Antoni Trilla, Raúl Ortiz de Lejarazu","doi":"10.1016/j.eimce.2024.08.006","DOIUrl":null,"url":null,"abstract":"<p><p>Despite high initial vaccination rates, Spain's current COVID-19 vaccination coverage in recommended groups does not meet WHO targets. For the upcoming season, challenges include revising vaccination age, updating risk groups, and unifying criteria with flu vaccine co-administration. European Commission's advance purchase agreements limit access to certain vaccines, and the need for vaccines effective against current variants adds administrative complexities. Spain's COVID-19 vaccination recommendations should adapt to these specific circumstances. Using vaccines effective against predominant variants with appropriate response duration is crucial to protect at-risk populations. Enhancing training and health education campaigns for health professionals and the general public, alongside utilizing tools to simplify vaccination recommendations, can promote higher vaccination rates in Spain. Addressing these challenges is essential to ensure adequate protection and improve vaccination coverage, ultimately achieving better public health outcomes in the face of evolving COVID-19 threats.</p>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":"43 1","pages":"36-46"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica (English ed.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.eimce.2024.08.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Despite high initial vaccination rates, Spain's current COVID-19 vaccination coverage in recommended groups does not meet WHO targets. For the upcoming season, challenges include revising vaccination age, updating risk groups, and unifying criteria with flu vaccine co-administration. European Commission's advance purchase agreements limit access to certain vaccines, and the need for vaccines effective against current variants adds administrative complexities. Spain's COVID-19 vaccination recommendations should adapt to these specific circumstances. Using vaccines effective against predominant variants with appropriate response duration is crucial to protect at-risk populations. Enhancing training and health education campaigns for health professionals and the general public, alongside utilizing tools to simplify vaccination recommendations, can promote higher vaccination rates in Spain. Addressing these challenges is essential to ensure adequate protection and improve vaccination coverage, ultimately achieving better public health outcomes in the face of evolving COVID-19 threats.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
西班牙新的COVID-19疫苗接种建议:为下一季进行优化
尽管初始疫苗接种率很高,但西班牙目前在推荐人群中的COVID-19疫苗接种覆盖率未达到世卫组织的目标。对于即将到来的季节,挑战包括修改疫苗接种年龄,更新风险群体,以及统一流感疫苗联合接种标准。欧洲委员会的预先购买协议限制了获得某些疫苗的机会,对有效预防当前变种的疫苗的需求增加了管理的复杂性。西班牙的COVID-19疫苗接种建议应适应这些具体情况。使用对主要变异体有效且反应持续时间适当的疫苗对于保护高危人群至关重要。加强对卫生专业人员和公众的培训和卫生教育运动,同时利用工具简化疫苗接种建议,可促进西班牙的疫苗接种率提高。应对这些挑战对于确保充分保护和提高疫苗接种覆盖率至关重要,面对不断变化的COVID-19威胁,最终实现更好的公共卫生成果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Analysis of the serological diagnosis of syphilis: A proposal for improvement. HIV and Chagas disease coinfection. How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations. Authors' reply. Which corticosteroid should be used in severe pneumonia? Indirect impact of PCV10 children vaccination on the serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive disease in adults over 50 in Colombia, 2005-2019: Observational analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1